• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Simulated Blockchain Platform Shows Feasibility for Secure Rare Disease Data Sharing

by
November 13, 2026
in Health
Reading Time: 3 mins read
0
Simulated Blockchain Platform Shows Feasibility for Secure Rare Disease Data Sharing

Simulated Blockchain Platform Shows Feasibility for Secure Rare Disease Data Sharing

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A multi-tier platform architecture designed to integrate electronic health records has demonstrated the preliminary technical feasibility of secure rare disease data sharing within a simulated research environment. Reported by investigators Que Wu, Linyue Ma, and Tiantian Dong in Archives of Public Health, the prototype was developed to address persistent data silos across medical institutions by activating underutilized clinical documentation. The authors evaluated their proposed system using synthetic clinical records alongside the Chinese Biomedical Language Understanding Evaluation benchmark, systematically examining named entity recognition accuracy, blockchain write throughput, latency, and dynamic de-identification performance in controlled laboratory conditions.

The research addresses the persistent fragmentation of rare disease data, an ongoing challenge that significantly hinders medical investigations and orphan drug development worldwide.

To overcome substantial variations in medical terminology across disparate clinical environments, the multi-tier platform integrates dedicated clinical semantic standardization tools. The system architecture incorporates the domain-adapted natural language processing model Rare-RoBERTa together with standardized ORPHA-codes to establish uniform clinical semantic classifications across heterogeneous hospital records.

The technical performance of the information extraction pipeline was formally evaluated using the Chinese Biomedical Language Understanding Evaluation benchmark. In simulated data governance evaluations, Rare-RoBERTa achieved an overall F1-score of 87.3 percent in named entity recognition.

To manage secure data exchange without relying on mutual institutional trust, the platform prototype was implemented using the Hyperledger Fabric blockchain. This decentralized ledger architecture facilitates zero-trust, fully audited data transactions across participating healthcare institutions. During technical simulation experiments designed to evaluate system performance and scalability, the simulated blockchain network achieved a peak write throughput of approximately 980 transactions per second under a simulated workload of 600 concurrent users while investigators systematically assessed transaction latency and ledger processing capabilities under synthetic operational conditions.

Data governance and patient confidentiality were assessed through the platform’s dynamic privacy-preserving de-identification mechanism, which aims to protect sensitive personal health information while retaining analytical utility for downstream clinical research. In simulated evaluations using synthetic records, the de-identification procedure restricted the estimated re-identification risk to below 0.08 percent. Simultaneously, the mechanism maintained research data utility, incurring a measured information loss of 14.5 percent during the privacy-preserving transformation process.

The authors explicitly emphasized that all reported operational metrics represent simulated technical performance within a controlled laboratory environment and must not be interpreted as evidence of clinical effectiveness or operational scalability in live hospital environments. Although the proposed architecture outlines a plausible preliminary foundation to reactivate dormant clinical data and potentially support future health equity, the authors concluded that rigorous multi-center pilot trials using real-world heterogeneous electronic health records remain essential prior to real-world clinical deployment, ultimately facilitating evidence-based policymaking and rare disease governance.

Subject of Research: System architecture and simulation of a secure rare disease data-sharing platform

Article Title: Designing a secure rare disease data-sharing platform leveraging electronic health records: a system architecture and simulation study

Article References: Wu, Q., Ma, L., & Dong, T. (2026). Designing a secure rare disease data-sharing platform leveraging electronic health records: a system architecture and simulation study. Archives of Public Health. https://doi.org/10.1186/s13690-026-02138-0

Image Credits: AI Generated

DOI: 10.1186/s13690-026-02138-0

Keywords: rare disease data sharing, electronic health records, Hyperledger Fabric, Rare-RoBERTa, ORPHA-codes, clinical semantic standardization, named entity recognition, CBLUE benchmark, zero-trust architecture, data silos, dynamic de-identification, re-identification risk, write throughput, orphan drug development, synthetic clinical records, rare disease governance

News Source: Ophelia Keating. (November 13, 2026). Simulated Blockchain Platform Shows Feasibility for Secure Rare Disease Data Sharing. Scienmag.

Tags: CBLUE benchmarkclinical semantic standardizationdata silosdynamic de-identificationelectronic health recordsHyperledger Fabricnamed entity recognitionORPHA-codesorphan drug developmentrare disease data sharingrare disease governanceRare-RoBERTare-identification risksynthetic clinical recordswrite throughputZero Trust Architecture
Share12Tweet7Share2ShareShareShare1

Related Posts

GLP-1 Receptor Agonists Significantly Reduce Cardiovascular Events in High-Risk Adults

GLP-1 Receptor Agonists Significantly Reduce Cardiovascular Events in High-Risk Adults

November 13, 2026
Rare Contrast-Induced Encephalopathy Follows Emergency Aortic Stent Repair in Case Study

Rare Contrast-Induced Encephalopathy Follows Emergency Aortic Stent Repair in Case Study

November 13, 2026

Decade Review Details Structural Evolution and Clinical Advances of PARP-1 Cancer Inhibitors

November 13, 2026

First Trimester Placental Growth Factor Levels Are Elevated in Gestational Diabetes

November 13, 2026

POPULAR NEWS

  • Dual Microbial Bioconvection Governs Flow Past Spherical Aerobic Granules in Simulations

    Dual Microbial Bioconvection Governs Flow Past Spherical Aerobic Granules in Simulations

    29 shares
    Share 12 Tweet 7
  • Engineered Bacteria Produce Marine Bacillus Bacteriocin Active Against Listeria

    29 shares
    Share 12 Tweet 7
  • Eco-Engineered Nanomaterials Offer Safer PFAS Remediation but Face Critical Performance Trade-Offs

    29 shares
    Share 12 Tweet 7
  • Sex Differences in Liver Disease Remodeling Follow Shared Directional Pathways

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Eutectic Engineering Yields Ultra-Low-Defect Perovskite Films for Solar Cells and LEDs

Endophytic Bacterium Burkholderia seminalis 869T2 Enhances Plant Growth Under Salt Stress

Over a Century of Releasing Domestic Ducks Altered Wild Mallard Genetics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.